The Clinical Trials Network
The Clinical Trials Network (CTNx) is a physician-founded Site Management Organization that provides infrastructure, regulatory, data, and operational support to a network of 90+ private practice research sites across 12 specialties, connecting them with pharmaceutical sponsors and CROs for clinical trial execution.
- Company typePrivate
- Founded2016
- HeadquartersCleveland, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What The Clinical Trials Network does
The Clinical Trials Network (CTNx) is a US-based, physician-founded Site Management Organization (SMO) that enables private practice physicians, multi-specialty groups, and hospital systems to launch and operate clinical research programs without building infrastructure in-house. Founded in 2016 by practicing gastroenterologist Dr. Keith Friedenberg and co-developer Chris Petek, the company operates a network of 90+ research sites across 12 therapeutic specialties (including Gastroenterology, Ophthalmology, Neurology, Dermatology, Allergy/Immunology, Cardiology, Endocrinology, Podiatry, Psychiatry, Pulmonology, Rheumatology, and Women's Health), with a stated track record of 400+ clinical trials facilitated and 11,000+ patients enrolled.
CTNx delivers a plug-and-play trial management platform built around a Clinical Trial Management System (CTMS)/eSource layer, augmented by third-party AI integrations: SelectIQ for EMR-driven patient identification and ranking, Virgo's HIPAA/SOC-2 endoscopy video AI for GI trials, and VersaTrial's browser-based study organizer. The company provides centralized regulatory, compliance, data management, and operational support via dedicated teams (Site Engagement, Data Operations, Research Integrity), and is reported to have achieved zero non-compliance letters across 85+ sites.
The business model combines Site Management Fees (infrastructure, compliance, data, and administrative support for partner sites) with Sponsor/CRO Site Placement Fees (connecting sponsors and CROs to qualified sites in the network). CTNx fronts nearly all trial startup costs for sites and operates on a fee-for-service basis with multi-year contracts. Go-to-market is hybrid: direct sales outreach by site engagement officers plus physician referral/word-of-mouth driven by the founder's own research practice credibility. The company remains privately held, founder-led, with no disclosed venture or private equity funding to date.
The Clinical Trials Network firmographics
Firmographics- Name
- The Clinical Trials Network
- Legal name
- The Clinical Trials Network
- Website
- https://thectnx.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Clinical Trials Network (CTNx) is a physician-founded Site Management Organization that provides infrastructure, regulatory, data, and operational support to a network of 90+ private practice research sites across 12 specialties, connecting them with pharmaceutical sponsors and CROs for clinical trial execution.
- Ownership category
- akta.pro rank
The Clinical Trials Network industry classification
Industry- Product category
- Clinical Trial Site Management Services
- NAICS
- Management Consulting Services (54161), Scientific Research and Development Services (5417)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Clinical Trial Management Systems (CTMS) (HLACAOAD)
Keywords
Where The Clinical Trials Network is headquartered
LocationHeadquarters
- HQ city
- Cleveland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
The Clinical Trials Network business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Site Management Fees: CTNx charges fees to research sites (private practices, multi-specialty groups, hospital systems) for providing infrastructure, administrative support, compliance oversight, data management, and access to a network of sponsors and CROs. CTNx fronts nearly all trial start-up costs for sites.
- Sponsor / CRO Site Placement Fees: CTNx earns fees by connecting sponsors and CROs with qualified research sites in their network. The network presents sites as high-enrolling, quality-focused partners to trial sponsors seeking patient recruitment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Site services — infrastructure and administrative support for private practice research sites |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
The Clinical Trials Network product offering
Product offeringCore offering
CTNx is a site management organization that provides turnkey clinical trial management services to private practice physicians, multi-specialty groups, and hospital systems, enabling them to launch and scale research programs without building their own infrastructure. The company fronts nearly all trial start-up costs, supplies regulatory, compliance, data management, and finance support, and connects partner sites with a curated network of 60+ sponsors and CROs across 12 therapeutic specialty networks.
Product overview
The Clinical Trials Network (CTNx) is a physician-founded clinical trial management company offering a comprehensive suite of services for private practices, multi-specialty groups, and hospital systems seeking to build or scale research programs. CTNx's core offering is its plug-and-play trial management services model, which provides centralized administrative support including site engagement (Kevin Ignasiak's team), data operations/site relations (Seth Brine's team), research integrity/compliance (Whitney Heath's team), and ongoing operations support. The company operates a network of research sites across 12 medical specialties. CTNx has formed strategic partnerships with SelectIQ for AI-powered patient recruitment, Virgo for GI endoscopy AI analysis, and VersaTrial for study organization.
Differentiator
Problem solved
Functional benefit
Products and services
- Trial Management Services
- Network of Research Sites (12 Specialty Networks)
- Site Engagement Services
- Data Operations / Site Relations Services
- Research Integrity / Compliance Services
Quantifiable outcome
- Trial start-up times reduced by 50%
- +5 more outcomes
Companies that use The Clinical Trials Network
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
The Clinical Trials Network technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability4 records
Feature4 records
The Clinical Trials Network partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- SelectIQcoreCTNx partnered with SelectIQ to leverage AI-powered patient recruitment for its research sites. SelectIQ integrates with a practice's EMR system to analyze patient records and flag individuals whose medical history aligns with clinical trial criteria, ranking them by likelihood of participation. CTNx staff then conducts outreach and pre-screening to connect qualified candidates with study coordinators.
- VersaTrialcoreCTNx adopted VersaTrial's Study Organizer platform to alleviate technology overload across its network. VersaTrial consolidates study information including technology portals, login credentials, and external contacts into an intelligent browser extension accessible within EDC, CTMS, and ePRO systems, saving study teams time and improving productivity.
- Virgo Surgical Video SolutionscoreCTNx partnered with Virgo to power GI clinical trials across its network of 30+ gastroenterology sites. Virgo's cloud-based, HIPAA- and SOC-2-compliant platform enables automatic recording, storage, and management of endoscopy videos, with AI tools analyzing inclusion/exclusion criteria to accelerate patient enrollment for trials in Ulcerative Colitis and Crohn's Disease.
- AdvertrialminorAdvertrial is listed as an official partner of CTNx on the company's website footer, suggesting a marketing or promotional partnership.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
The Clinical Trials Network competitors and assessment
Company assessmentBroad incumbents
- Parexel: Global CRO that works directly with CTNx's sites (per Parexel's Donna Keough testimonial) and represents a key buyer of the kind of community-site access CTNx is built to provide.
- IQVIA: Largest global CRO with embedded site services; CTNx's Dan Nwosu came from IQVIA, and the firm represents both a competitor for sponsor study placement and a potential channel partner for community-site demand.
- Medpace: Mid-to-large full-service CRO with growing site network capabilities; represents a comparable end-to-end clinical research delivery model against which CTNx's site-only offering must differentiate.
- ICON plc: Global CRO with site services and decentralized trial capabilities; relevant comparable for sponsor-side buyer expectations on site quality, compliance, and recruitment scale.
Direct peers
- Elligo Health Research: Directly comparable SMO that brings clinical research to community-based physicians using a 'Goes Research' model, paralleling CTNx's plug-and-play approach to activating private practice sites.
- Velocity Clinical Research: Multi-specialty SMO operating dedicated research sites across therapeutic areas; comparable to CTNx in its site-network, multi-therapeutic model and sponsor-facing service offering.
- WCG Clinical: Clinical research services and site enablement platform with deep sponsor and CRO relationships; comparable to CTNx in the site-oversight and compliance services it sells into the same buyer base.
- ClinEdge: SMO and site services provider supporting research site operations, patient recruitment, and regulatory compliance; comparable in scope of services delivered to private practice sites.
Emerging players
- Science 37: Decentralized clinical trial platform that, like CTNx, addresses limitations of traditional academic sites; adjacent in that it competes for sponsor demand for community-based patient access, though via a different operating model.
- Clario: Clinical trial technology and endpoint services provider; comparable in the technology-enabled clinical trial operations space and a potential partner for CTNx's CTMS/eSource roadmap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
The Clinical Trials Network social profiles
Digital presenceThe Clinical Trials Network financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Clinical Trials Network leadership team
Management profileNumber of profiles
Profiles8 records
The Clinical Trials Network funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Clinical Trials Network M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Clinical Trials Network
What does The Clinical Trials Network do?
CTNx is a site management organization that provides turnkey clinical trial management services to private practice physicians, multi-specialty groups, and hospital systems, enabling them to launch and scale research programs without building their own infrastructure. The company fronts nearly all trial start-up costs, supplies regulatory, compliance, data management, and finance support, and connects partner sites with a curated network of 60+ sponsors and CROs across 12 therapeutic specialty networks.
Is The Clinical Trials Network a public or private company?
The Clinical Trials Network is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was The Clinical Trials Network founded?
The Clinical Trials Network was founded in 2016. It employs 51 to 100 people.
Where is The Clinical Trials Network based?
The Clinical Trials Network is headquartered in Cleveland, United States, in the North America region.
How does The Clinical Trials Network make money?
Two revenue lines are on record. Site Management Fees are the primary driver. The others are sponsor / CRO Site Placement Fees.
Who are The Clinical Trials Network's main competitors?
Broad incumbents on record are Parexel, IQVIA, Medpace and ICON plc. Direct peers are Elligo Health Research, Velocity Clinical Research, WCG Clinical and ClinEdge. Emerging players are Science 37 and Clario.
Does The Clinical Trials Network have an API?
No public API is recorded for The Clinical Trials Network.
What industry is The Clinical Trials Network in?
The Clinical Trials Network's product category is Clinical Trial Site Management Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLACAOAD, Clinical Trial Management Systems (CTMS). Its NAICS code is 54161 and its SIC code is 8011.